We report the five- to-ten year results of Anderson Orthopaedic Research Institute type-2 bone defects treated with modular metal augments in revision knee surgery.

A total of 102 revision knee arthroplasties in patients with type-2 defects treated with augments and stems were prospectively studied. Seven patients (seven knees) had incomplete follow-up and 15 patients (16 knees) died with the arthroplasty in situ. The mean follow-up of the 79 remaining knees was 7 ± 2 years (5 to 11). The presence of non-progressive radiolucent lines around the augment in 14% of knees was not associated with poorer knee scores, the range of movement, survival of the component or the type of insert which was used (p > 0.05). The survival of the components was 92 ± 0.03% at 11 years (95% CI, 10.3 to 11.2).

We recommend the use of modular augmentation devices to treat type-2 defects in revision knee surgery.

We report on five-ten year results of AORI type two bone defects treated with modular augments in revision knee surgery.

102 revision knee arthroplasties with type two defects were treated with augments & stems and minimum five-year follow-up were prospectively studied.

15 patients (16 knees) died with retention of their prosthesis, 7 knees had incomplete follow-up. There were 79 remaining knees with complete follow-up of 7+−2 years (range: 5 – 11). The presence of non-progressive radiolucent lines around the augment in 20% of knees was not associated with poorer knee scores, range of motion, component survival or type of insert used (p> 0.05). Kaplan-Meier survival of the components was 92+− 0.03% at 11 years (95%CI:10.3–11.2)

We support the use of modular augmentation devices to treat type 2 defects in revision knee surgery and conclude that theoretical concerns of fretting and loosening based on 5 – 10 year clinical data are unfounded.